Through a series of projects, Siemens Healthineers will work with Ohio State Wexner Medical Center over five years to personalize cancer diagnostics and therapeutics.

Among the work is the outpatient expansion of The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James). Siemens will install imaging systems, including its Biograph Vision 600 Digital PET scanner; the Artis Q Ceiling solution for oncology-focused interventional radiology; and Somatom Drive and Somatom Force for Dual Source Dual Energy CT.

Prior to its acquisition by Siemens, Varian worked with the institute for nearly a decade. It will help construct the Outpatient Care West Campus, which is set to open in 2023, installing there its ProBeam 360° proton therapy system and the Edge radiosurgery platform. Its Eclipse platform will be used for treatment planning. “With Varian, Siemens Healthineers is ideally positioned to pioneer the next generation of cancer technology that addresses the growing need for personalized cancer care,” said David Pacitti, president of Siemens Medical Solutions USA, Inc. and head of the Americas at Siemens Healthineers, in a statement.
Siemens also plans to bring new technologies to Ohio’s State’s inpatient hospital, which will open in 2026, as well as three other outpatient facilities. Additionally, it will work with researchers at OSUCCC-James to develop intelligent radiation dosimetric contouring algorithms that will use clinical, pathology and genomic data to tailor care to individual patients and improve decision-making.

Another focus is the development of advanced cardiac imaging methods for Siemens’ Magnetom Free.Max MR system, which scored FDA clearance in 2021. With no quench pipe, the whole-body scanner is less costly to install, and uses less than one liter of helium. It also has an 80 cm bore for imaging larger and claustrophobic patients. The new scanning protocols will expand its use to other patient populations that also can be difficult to scan.

In addition, both organizations will utilize the Corindus CorPath GRX system to make highly specialized endovascular procedures more precise and accessible to patients. “Together we will research ways technology can accelerate breakthrough health discoveries and the care delivery process for all patients in the future," said Peter Mohler, vice president for research at The Ohio State University and chief scientific officer at its Wexner Medical Center.

Back to HCB News

CT Homepage